Our Science
Tumor Activated Therapy™
Tumor growth induces many biochemical modifications of the micro-environment (TME) that are essential for cancer progression and dissemination.
By taking advantage of the TME hallmarks, the Tumor Activated Therapy™ stimulates the tumor to induce its own destruction.
The Tumor Activated Therapy™ targets functional proteins produced by the tumor in the TME, enabling both tumor recognition and selective drug activation.
Its Mode of Action is independent of any specific hallmarks of cancer cell (e.g. expression of specific surface markers like Antigens, membrane receptors…).
This unique property allows to overcome issues associated to tumor heterogeneity.
Additionally, a wide range of solid tumors (including difficult-to-treat tumors such as lung, pancreatic, Triple Negative Breast Cancer and colon cancers) can be successfully treated thanks to this novel and unique Mode of Action.